Nevertheless, most of the studies assessing the antibiofilm activity of candidate AMPs have been performed using in vitro models in which the conditions are very different from those found in vivo at the site of infection (Lebeaux et al., 2013; Roberts et al., 2015). The gene discussed is ADSL; the disease is infection.